Review Article
The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
Table 1
Targeted responses to systemic menopause treatments [
6–
11].
| Target | SERMs Ral, BZA | Estrogen | STEAR (tibolone) | TSEC (BZA/CE) |
| Uterus | 0 | − | = | 0 | Hot flushes | − | + | + | + | Vagina | − | + | + | + | Bone | + | + | + | + | Breast | + | 0 | = | 0 | Sexual function | = | + | ++ | + | Energy levels | = | + | ++ | + |
|
|
STERM: selective estrogen receptor modulator; Ral: raloxifene; BZA: bazedoxifene; STEAR: selective tissue estrogenic activity regulator (tibolone); TSEC: tissue selective estrogen complex = BZA + CE; +: positive effect; ++: very positive effect; −: negative effect; =: neutral effect.
|